Stryker posted solid third-quarter results despite hurricanes, a product recall, and other headwinds.
News & Features
BD still plans to enter the estimated $1 billion market for insulin patch pumps for patients with type 2 diabetes, but its first product won't launch as soon as the company initially anticipated.
FDA and Philips reached an agreement regarding manufacturing issues involving the company's automatic external defibrillators.
Faced with an ongoing CEO search and manufacturing problems, Zimmer Biomet's third-quarter financials missed the mark on both revenue and earnings per share. But there may be a turnaround in sight.
There is a fine line that, when crossed, turns a sales rep from an asset to both manufacturers and surgeons into a potential liability for third-party claims.
A digital labeling expert points out that adopting digital processes might have benefits for multiple areas of medical device manufacturing.
After a six-year hiatus from the coronary stent business, Cordis just inked an exclusive distribution deal for two heart stents.
Working in the medical device and diagnostics industry is inspiring, exciting, and more than worthwhile. But, like any career, it can have its ups and downs.
CEO Joe Almeida said M&A deals, particularly smaller tuck-in acquisitions, will continue to play a key role in Baxter's growth strategy.
Recovery technology mogul Game Ready received FDA 510(k) clearance for its rehabilitation therapy that provides orthopedic treatment options for patients around the world.
With a spate of hurricanes, wildfires, and earthquakes front of mind, here's what medtech companies can do to fortify against future natural disasters.
These are the three questions vendors need to answer during research and development for their clinical wearable to be adopted enthusiastically by hospitals, patients, and doctors.